Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oral Insulin Market Growth 2022-2028

  • LP 4949684
  • 91 Pages
  • April 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Oral Insulin will have significant change from previous year. According to our (LP Information) latest study, the global Oral Insulin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Insulin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Oral Insulin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Oral Insulin market, reaching US$ million by the year 2028. As for the Europe Oral Insulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Oral Insulin players cover Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, and Diabetology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Insulin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Type 1 Diabetes

Type 2 Diabetes

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Female

Male

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novo Nordisk

Oramed Pharmaceuticals

vTv Therapeutics

Diabetology

Generex Biotechnology

Coromed

Nektar Therapeutics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Insulin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Insulin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Insulin by Country/Region, 2017, 2022 & 2028

2.2 Oral Insulin Segment by Type

2.2.1 Type 1 Diabetes

2.2.2 Type 2 Diabetes

2.3 Oral Insulin Sales by Type

2.3.1 Global Oral Insulin Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Insulin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Insulin Sale Price by Type (2017-2022)

2.4 Oral Insulin Segment by Application

2.4.1 Female

2.4.2 Male

2.5 Oral Insulin Sales by Application

2.5.1 Global Oral Insulin Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Insulin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Insulin Sale Price by Application (2017-2022)

3 Global Oral Insulin by Company

3.1 Global Oral Insulin Breakdown Data by Company

3.1.1 Global Oral Insulin Annual Sales by Company (2020-2022)

3.1.2 Global Oral Insulin Sales Market Share by Company (2020-2022)

3.2 Global Oral Insulin Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Insulin Revenue by Company (2020-2022)

3.2.2 Global Oral Insulin Revenue Market Share by Company (2020-2022)

3.3 Global Oral Insulin Sale Price by Company

3.4 Key Manufacturers Oral Insulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Insulin Product Location Distribution

3.4.2 Players Oral Insulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Insulin by Geographic Region

4.1 World Historic Oral Insulin Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Insulin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Insulin Annual Revenue by Geographic Region

4.2 World Historic Oral Insulin Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Insulin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Insulin Annual Revenue by Country/Region

4.3 Americas Oral Insulin Sales Growth

4.4 APAC Oral Insulin Sales Growth

4.5 Europe Oral Insulin Sales Growth

4.6 Middle East & Africa Oral Insulin Sales Growth

5 Americas

5.1 Americas Oral Insulin Sales by Country

5.1.1 Americas Oral Insulin Sales by Country (2017-2022)

5.1.2 Americas Oral Insulin Revenue by Country (2017-2022)

5.2 Americas Oral Insulin Sales by Type

5.3 Americas Oral Insulin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Insulin Sales by Region

6.1.1 APAC Oral Insulin Sales by Region (2017-2022)

6.1.2 APAC Oral Insulin Revenue by Region (2017-2022)

6.2 APAC Oral Insulin Sales by Type

6.3 APAC Oral Insulin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Insulin by Country

7.1.1 Europe Oral Insulin Sales by Country (2017-2022)

7.1.2 Europe Oral Insulin Revenue by Country (2017-2022)

7.2 Europe Oral Insulin Sales by Type

7.3 Europe Oral Insulin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Insulin by Country

8.1.1 Middle East & Africa Oral Insulin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Insulin Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Insulin Sales by Type

8.3 Middle East & Africa Oral Insulin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Insulin

10.3 Manufacturing Process Analysis of Oral Insulin

10.4 Industry Chain Structure of Oral Insulin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Insulin Distributors

11.3 Oral Insulin Customer

12 World Forecast Review for Oral Insulin by Geographic Region

12.1 Global Oral Insulin Market Size Forecast by Region

12.1.1 Global Oral Insulin Forecast by Region (2023-2028)

12.1.2 Global Oral Insulin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Insulin Forecast by Type

12.7 Global Oral Insulin Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Oral Insulin Product Offered

13.1.3 Novo Nordisk Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

13.2 Oramed Pharmaceuticals

13.2.1 Oramed Pharmaceuticals Company Information

13.2.2 Oramed Pharmaceuticals Oral Insulin Product Offered

13.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Oramed Pharmaceuticals Main Business Overview

13.2.5 Oramed Pharmaceuticals Latest Developments

13.3 vTv Therapeutics

13.3.1 vTv Therapeutics Company Information

13.3.2 vTv Therapeutics Oral Insulin Product Offered

13.3.3 vTv Therapeutics Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 vTv Therapeutics Main Business Overview

13.3.5 vTv Therapeutics Latest Developments

13.4 Diabetology

13.4.1 Diabetology Company Information

13.4.2 Diabetology Oral Insulin Product Offered

13.4.3 Diabetology Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Diabetology Main Business Overview

13.4.5 Diabetology Latest Developments

13.5 Generex Biotechnology

13.5.1 Generex Biotechnology Company Information

13.5.2 Generex Biotechnology Oral Insulin Product Offered

13.5.3 Generex Biotechnology Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Generex Biotechnology Main Business Overview

13.5.5 Generex Biotechnology Latest Developments

13.6 Coromed

13.6.1 Coromed Company Information

13.6.2 Coromed Oral Insulin Product Offered

13.6.3 Coromed Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Coromed Main Business Overview

13.6.5 Coromed Latest Developments

13.7 Nektar Therapeutics

13.7.1 Nektar Therapeutics Company Information

13.7.2 Nektar Therapeutics Oral Insulin Product Offered

13.7.3 Nektar Therapeutics Oral Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Nektar Therapeutics Main Business Overview

13.7.5 Nektar Therapeutics Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Oral Insulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Insulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Type 1 Diabetes

Table 4. Major Players of Type 2 Diabetes

Table 5. Global Oral Insulin Sales by Type (2017-2022) & (K Units)

Table 6. Global Oral Insulin Sales Market Share by Type (2017-2022)

Table 7. Global Oral Insulin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Oral Insulin Revenue Market Share by Type (2017-2022)

Table 9. Global Oral Insulin Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Oral Insulin Sales by Application (2017-2022) & (K Units)

Table 11. Global Oral Insulin Sales Market Share by Application (2017-2022)

Table 12. Global Oral Insulin Revenue by Application (2017-2022)

Table 13. Global Oral Insulin Revenue Market Share by Application (2017-2022)

Table 14. Global Oral Insulin Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Oral Insulin Sales by Company (2020-2022) & (K Units)

Table 16. Global Oral Insulin Sales Market Share by Company (2020-2022)

Table 17. Global Oral Insulin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Oral Insulin Revenue Market Share by Company (2020-2022)

Table 19. Global Oral Insulin Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Oral Insulin Producing Area Distribution and Sales Area

Table 21. Players Oral Insulin Products Offered

Table 22. Oral Insulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Oral Insulin Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Oral Insulin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Oral Insulin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Oral Insulin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Oral Insulin Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Oral Insulin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Oral Insulin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Oral Insulin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Oral Insulin Sales by Country (2017-2022) & (K Units)

Table 34. Americas Oral Insulin Sales Market Share by Country (2017-2022)

Table 35. Americas Oral Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Oral Insulin Revenue Market Share by Country (2017-2022)

Table 37. Americas Oral Insulin Sales by Type (2017-2022) & (K Units)

Table 38. Americas Oral Insulin Sales Market Share by Type (2017-2022)

Table 39. Americas Oral Insulin Sales by Application (2017-2022) & (K Units)

Table 40. Americas Oral Insulin Sales Market Share by Application (2017-2022)

Table 41. APAC Oral Insulin Sales by Region (2017-2022) & (K Units)

Table 42. APAC Oral Insulin Sales Market Share by Region (2017-2022)

Table 43. APAC Oral Insulin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Oral Insulin Revenue Market Share by Region (2017-2022)

Table 45. APAC Oral Insulin Sales by Type (2017-2022) & (K Units)

Table 46. APAC Oral Insulin Sales Market Share by Type (2017-2022)

Table 47. APAC Oral Insulin Sales by Application (2017-2022) & (K Units)

Table 48. APAC Oral Insulin Sales Market Share by Application (2017-2022)

Table 49. Europe Oral Insulin Sales by Country (2017-2022) & (K Units)

Table 50. Europe Oral Insulin Sales Market Share by Country (2017-2022)

Table 51. Europe Oral Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Oral Insulin Revenue Market Share by Country (2017-2022)

Table 53. Europe Oral Insulin Sales by Type (2017-2022) & (K Units)

Table 54. Europe Oral Insulin Sales Market Share by Type (2017-2022)

Table 55. Europe Oral Insulin Sales by Application (2017-2022) & (K Units)

Table 56. Europe Oral Insulin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Oral Insulin Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Oral Insulin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Oral Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Oral Insulin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Oral Insulin Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Oral Insulin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Oral Insulin Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Oral Insulin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Oral Insulin

Table 66. Key Market Challenges & Risks of Oral Insulin

Table 67. Key Industry Trends of Oral Insulin

Table 68. Oral Insulin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Oral Insulin Distributors List

Table 71. Oral Insulin Customer List

Table 72. Global Oral Insulin Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Oral Insulin Sales Market Forecast by Region

Table 74. Global Oral Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Oral Insulin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Oral Insulin Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Oral Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Oral Insulin Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Oral Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Oral Insulin Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Oral Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Oral Insulin Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Oral Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Oral Insulin Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Oral Insulin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Oral Insulin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Oral Insulin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Oral Insulin Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Oral Insulin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Oral Insulin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Oral Insulin Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novo Nordisk Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 93. Novo Nordisk Oral Insulin Product Offered

Table 94. Novo Nordisk Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Novo Nordisk Main Business

Table 96. Novo Nordisk Latest Developments

Table 97. Oramed Pharmaceuticals Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 98. Oramed Pharmaceuticals Oral Insulin Product Offered

Table 99. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Oramed Pharmaceuticals Main Business

Table 101. Oramed Pharmaceuticals Latest Developments

Table 102. vTv Therapeutics Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 103. vTv Therapeutics Oral Insulin Product Offered

Table 104. vTv Therapeutics Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. vTv Therapeutics Main Business

Table 106. vTv Therapeutics Latest Developments

Table 107. Diabetology Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 108. Diabetology Oral Insulin Product Offered

Table 109. Diabetology Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Diabetology Main Business

Table 111. Diabetology Latest Developments

Table 112. Generex Biotechnology Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 113. Generex Biotechnology Oral Insulin Product Offered

Table 114. Generex Biotechnology Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Generex Biotechnology Main Business

Table 116. Generex Biotechnology Latest Developments

Table 117. Coromed Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 118. Coromed Oral Insulin Product Offered

Table 119. Coromed Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Coromed Main Business

Table 121. Coromed Latest Developments

Table 122. Nektar Therapeutics Basic Information, Oral Insulin Manufacturing Base, Sales Area and Its Competitors

Table 123. Nektar Therapeutics Oral Insulin Product Offered

Table 124. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Nektar Therapeutics Main Business

Table 126. Nektar Therapeutics Latest Developments

List of Figures

Figure 1. Picture of Oral Insulin

Figure 2. Oral Insulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Insulin Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Oral Insulin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Insulin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Type 1 Diabetes

Figure 10. Product Picture of Type 2 Diabetes

Figure 11. Global Oral Insulin Sales Market Share by Type in 2021

Figure 12. Global Oral Insulin Revenue Market Share by Type (2017-2022)

Figure 13. Oral Insulin Consumed in Female

Figure 14. Global Oral Insulin Market: Female (2017-2022) & (K Units)

Figure 15. Oral Insulin Consumed in Male

Figure 16. Global Oral Insulin Market: Male (2017-2022) & (K Units)

Figure 17. Global Oral Insulin Sales Market Share by Application (2017-2022)

Figure 18. Global Oral Insulin Revenue Market Share by Application in 2021

Figure 19. Oral Insulin Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Oral Insulin Revenue Market Share by Company in 2021

Figure 21. Global Oral Insulin Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Oral Insulin Revenue Market Share by Geographic Region in 2021

Figure 23. Global Oral Insulin Sales Market Share by Region (2017-2022)

Figure 24. Global Oral Insulin Revenue Market Share by Country/Region in 2021

Figure 25. Americas Oral Insulin Sales 2017-2022 (K Units)

Figure 26. Americas Oral Insulin Revenue 2017-2022 ($ Millions)

Figure 27. APAC Oral Insulin Sales 2017-2022 (K Units)

Figure 28. APAC Oral Insulin Revenue 2017-2022 ($ Millions)

Figure 29. Europe Oral Insulin Sales 2017-2022 (K Units)

Figure 30. Europe Oral Insulin Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Oral Insulin Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Oral Insulin Revenue 2017-2022 ($ Millions)

Figure 33. Americas Oral Insulin Sales Market Share by Country in 2021

Figure 34. Americas Oral Insulin Revenue Market Share by Country in 2021

Figure 35. United States Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Oral Insulin Sales Market Share by Region in 2021

Figure 40. APAC Oral Insulin Revenue Market Share by Regions in 2021

Figure 41. China Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Oral Insulin Sales Market Share by Country in 2021

Figure 48. Europe Oral Insulin Revenue Market Share by Country in 2021

Figure 49. Germany Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Oral Insulin Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Oral Insulin Revenue Market Share by Country in 2021

Figure 56. Egypt Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Oral Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Oral Insulin in 2021

Figure 62. Manufacturing Process Analysis of Oral Insulin

Figure 63. Industry Chain Structure of Oral Insulin

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390